GSA Capital Partners’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $181K | Buy |
+82,343
| New | +$181K | 0.01% | 1533 |
|
|
2024
Q4 | – | Sell |
-182,725
| Closed | -$623K | – | 1705 |
|
|
2024
Q3 | $623K | Buy |
182,725
+86,020
| +89% | +$293K | 0.05% | 774 |
|
|
2024
Q2 | $452K | Buy |
96,705
+49,303
| +104% | +$230K | 0.03% | 1030 |
|
|
2024
Q1 | $352K | Buy |
+47,402
| New | +$352K | 0.03% | 1112 |
|
|
2023
Q4 | – | Sell |
-20,141
| Closed | -$157K | – | 1591 |
|
|
2023
Q3 | $157K | Buy |
+20,141
| New | +$157K | 0.01% | 1329 |
|
|
2023
Q2 | – | Sell |
-20,549
| Closed | -$149K | – | 1607 |
|
|
2023
Q1 | $149K | Buy |
20,549
+1,803
| +10% | +$13.1K | 0.01% | 1306 |
|
|
2022
Q4 | $166K | Sell |
18,746
-1,760
| -9% | -$15.6K | 0.02% | 1229 |
|
|
2022
Q3 | $251K | Sell |
20,506
-48,494
| -70% | -$594K | 0.03% | 1049 |
|
|
2022
Q2 | $816K | Buy |
69,000
+56,876
| +469% | +$673K | 0.12% | 221 |
|
|
2022
Q1 | $231K | Buy |
12,124
+923
| +8% | +$17.6K | 0.03% | 1081 |
|
|
2021
Q4 | $297K | Buy |
11,201
+4,337
| +63% | +$115K | 0.04% | 938 |
|
|
2021
Q3 | $282K | Buy |
+6,864
| New | +$282K | 0.03% | 1061 |
|
|
2019
Q3 | – | Sell |
-15,817
| Closed | -$391K | – | 1469 |
|
|
2019
Q2 | $391K | Sell |
15,817
-16,283
| -51% | -$403K | 0.04% | 821 |
|
|
2019
Q1 | $785K | Buy |
+32,100
| New | +$785K | 0.08% | 426 |
|
|
2018
Q2 | – | Sell |
-26,285
| Closed | -$871K | – | 1741 |
|
|
2018
Q1 | $871K | Buy |
+26,285
| New | +$871K | 0.05% | 751 |
|
|
2017
Q4 | – | Sell |
-27,800
| Closed | -$667K | – | 1611 |
|
|
2017
Q3 | $667K | Buy |
+27,800
| New | +$667K | 0.05% | 774 |
|